ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of January 2025

Stock Information for abrdn Life Sciences Investors Shares of Beneficial Interest

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About abrdn Life Sciences Investors Shares of Beneficial Interest

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of May 2025
ArrowMark Financial Corp. Announces Q1 2025 Results and Cash Distribution of $0.45 per Share for the Second Quarter 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of March 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of February 2025
ArrowMark Financial Corp. Announces Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the First Quarter 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of December 2024
ArrowMark Financial Corp. Announces Q3 2024 Results and Releases Month End Estimated Net Asset Value as of November 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.